Provectus Biopharmaceuticals (PVCT) Interest Expenses (2018 - 2026)
Provectus Biopharmaceuticals' Interest Expenses came in at $50,319 for Q2 2026, down 2.0% from $51,353 a year earlier.
Powered by 
Analysis
Provectus Biopharmaceuticals (PVCT) Interest Expenses (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Provectus Biopharmaceuticals reported Interest Expenses of $121,287, down 76.8% year-over-year; for FY2021, it was $961,702, down 45.0% from FY2020.
- Interest Expenses carries a three-year compound annual growth rate of -0.3% (FY2018 to FY2021).
- Going back by year, Interest Expenses was $1.75 million in FY2020 (+20.1%), $1.46 million in FY2019 (+50.1%) and $969,715 in FY2018.
- The Q2 2026 figure represents the lowest quarterly Interest Expenses since Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | - |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 462.00 Mn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 435.00 Mn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | - |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - | 50,319.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50,319.00 |
| Jun 30, 2025 | 51,353.00 |
| Dec 31, 2021 | 16,093.00 |
| Sep 30, 2021 | 3,522.00 |
| Jun 30, 2021 | 452,812.00 |
| Mar 31, 2021 | 489,275.00 |
| Dec 31, 2020 | 469,175.00 |
| Sep 30, 2020 | 463,390.00 |
| Jun 30, 2020 | 410,404.00 |
| Mar 31, 2020 | 405,151.00 |
| Dec 31, 2019 | 386,484.00 |
| Sep 30, 2019 | 377,576.00 |
| Jun 30, 2019 | 356,451.00 |
| Mar 31, 2019 | 334,573.00 |
| Dec 31, 2018 | 272,501.00 |
| Sep 30, 2018 | 256,173.00 |
| Jun 30, 2018 | 234,473.00 |
API Access
Provectus Biopharmaceuticals Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=PVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();